Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Exemed Pharmaceuticals, also known as Exemed Pharma, is a prominent pharmaceutical manufacturer with its headquarters situated in Nagpur, Maharashtra, India. Established in 2004, this medicinal and botanical manufacturing company operates a state-of-the-art, USFDA and EU-GMP approved facility in Ankleshwar, Gujarat.
Specialising in Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and Finished Dosage Forms (FDFs), Exemed Pharmaceuticals delivers high-quality, cost-effective solutions globally. Its commitment to rigorous research and development, coupled with extensive contract manufacturing capabilities, positions it as a reliable partner in the pharmaceutical industry.
-12 vs industry average
Exemed Pharmaceuticals’s score of 5 is lower than 5% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medicinal and Botanical Manufacturing is among the most carbon-intensive industries
The Medicinal and Botanical Manufacturing industry has reduced its overall emissions by 28% since 2018
No reported emissions data is available for Exemed Pharmaceuticals yet.
Exemed Pharmaceuticals, a Medicinal and Botanical Manufacturing company headquartered in India, has not publicly reported its carbon emissions data. However, the company has demonstrated a commitment to climate action. Exemed Pharmaceuticals has committed to Net Zero emissions, with its near-term and net-zero targets registered as "Committed" with the Science Based Targets initiative (SBTi). Additionally, medac Pharma LLP, which may be related to Exemed Pharmaceuticals, has committed to achieving Net Zero emissions by 2045 and reducing carbon emissions by 30% by 2045, based on a January 2024 leadership team commitment.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Exemed Pharmaceuticals’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more